Already FDA-approved to treat major depression and migraines, TMS can now be marketed as a treatment for obsessive compulsive disorder Santa Barbara, Calif., September 21, 2018 – Transcranial Magnetic Stimulation (TMS) therapy is rapidly growing in popularity as a treatment [..]
Leading National TMS provider—more locations, more doctors, more experience, more success!
Genetic Testing
Most mood disorder patients (particularly those who have failed a current drug regimen) will have a genetic test done to instruct on a variety of pre-treatment issues (e.g. whether the genetic makeup of the patient is indicated for a prescribed drug, among others).
Insurance coverage is widely available
Insurance Coverage Information
Patient Self Assessment & Tools
TMS Information for Practitioners
APA Guidelines
TMS Success Stories
NEWS / RESEARCH
